Stephen Jun Fei Chong

740 total citations
21 papers, 490 citations indexed

About

Stephen Jun Fei Chong is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Stephen Jun Fei Chong has authored 21 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Immunology. Recurrent topics in Stephen Jun Fei Chong's work include Cell death mechanisms and regulation (9 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Mitochondrial Function and Pathology (3 papers). Stephen Jun Fei Chong is often cited by papers focused on Cell death mechanisms and regulation (9 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Mitochondrial Function and Pathology (3 papers). Stephen Jun Fei Chong collaborates with scholars based in Singapore, United States and France. Stephen Jun Fei Chong's co-authors include Shazib Pervaiz, Ivan Cherh Chiet Low, Matthew S. Davids, Saverio Marchi, Giulia Petroni, Lorenzo Galluzzi, Guido Kroemer, Natalie Y.L. Ngoi, Marie‐Véronique Clement and Jianhua Qu and has published in prestigious journals such as Nucleic Acids Research, Blood and Cancer Research.

In The Last Decade

Stephen Jun Fei Chong

19 papers receiving 487 citations

Peers

Stephen Jun Fei Chong
Chenzhong Xu China
Iha Park South Korea
Yan Meng China
Patricia de la Cruz‐Ojeda Spain
Marie‐Julie Nokin Belgium
John Marentette United States
Junyong Han China
Giselle Pinto de Faria Lopes Brazil
Mariya Misheva United Kingdom
Lingyun Zheng China
Chenzhong Xu China
Stephen Jun Fei Chong
Citations per year, relative to Stephen Jun Fei Chong Stephen Jun Fei Chong (= 1×) peers Chenzhong Xu

Countries citing papers authored by Stephen Jun Fei Chong

Since Specialization
Citations

This map shows the geographic impact of Stephen Jun Fei Chong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Jun Fei Chong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Jun Fei Chong more than expected).

Fields of papers citing papers by Stephen Jun Fei Chong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Jun Fei Chong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Jun Fei Chong. The network helps show where Stephen Jun Fei Chong may publish in the future.

Co-authorship network of co-authors of Stephen Jun Fei Chong

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Jun Fei Chong. A scholar is included among the top collaborators of Stephen Jun Fei Chong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Jun Fei Chong. Stephen Jun Fei Chong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chong, Stephen Jun Fei, Kartini Iskandar, Chuqi Wang, et al.. (2025). Superoxide-mediated phosphorylation and stabilization of Mcl-1 by AKT underlie venetoclax resistance in hematologic malignancies. Leukemia. 39(10). 2477–2491. 2 indexed citations
2.
Chong, Stephen Jun Fei, Junyan Lu, Rebecca Valentin, et al.. (2025). BCL-2 dependence is a favorable predictive marker of response to therapy for chronic lymphocytic leukemia. Molecular Cancer. 24(1). 62–62. 2 indexed citations
3.
Wang, Jing, et al.. (2024). Mechanistic Insights and Therapeutic Potential of a PRMT5 Inhibitor Combined with Venetoclax in B Cell Malignancies. Blood. 144(Supplement 1). 1615–1615. 1 indexed citations
4.
Crombie, Jennifer L., Wei Ni, Swati Garg, et al.. (2023). Hypomethylating agent decitabine sensitizes diffuse large B-cell lymphoma to venetoclax. Haematologica. 109(1). 186–199. 7 indexed citations
5.
Chong, Stephen Jun Fei, et al.. (2022). Abstract 3959: Targeting BCL2 family protein phosphorylation in venetoclax resistant lymphoid malignancies. Cancer Research. 82(12_Supplement). 3959–3959. 1 indexed citations
6.
Ryan, Christine E., et al.. (2022). Inhibition of PRMT5 Increases Sensitivity to BH3 Mimetics in Aggressive B Cell Malignancies. Blood. 140(Supplement 1). 8842–8843.
7.
Ngoi, Natalie Y.L., et al.. (2021). The redox-senescence axis and its therapeutic targeting. Redox Biology. 45. 102032–102032. 58 indexed citations
8.
Qu, Jianhua, Biao Zheng, Kenoki Ohuchida, et al.. (2021). PIK3CB is involved in metastasis through the regulation of cell adhesion to collagen I in pancreatic cancer. Journal of Advanced Research. 33. 127–140. 22 indexed citations
9.
Chong, Stephen Jun Fei, Saverio Marchi, Giulia Petroni, et al.. (2020). Noncanonical Cell Fate Regulation by Bcl-2 Proteins. Trends in Cell Biology. 30(7). 537–555. 79 indexed citations
10.
11.
12.
Chong, Stephen Jun Fei, et al.. (2020). Peroxynitrite promotes serine-62 phosphorylation-dependent stabilization of the oncoprotein c-Myc. Redox Biology. 34. 101587–101587. 19 indexed citations
13.
Zheng, Biao, Jianhua Qu, Kenoki Ohuchida, et al.. (2020). LAMA4 upregulation is associated with high liver metastasis potential and poor survival outcome of Pancreatic Cancer. Theranostics. 10(22). 10274–10289. 26 indexed citations
14.
Chong, Stephen Jun Fei, Kartini Iskandar, Jianhua Qu, et al.. (2020). Serine-70 phosphorylated Bcl-2 prevents oxidative stress-induced DNA damage by modulating the mitochondrial redox metabolism. Nucleic Acids Research. 48(22). 12727–12745. 37 indexed citations
15.
Chong, Stephen Jun Fei, Jianhua Qu, Jayshree L. Hirpara, et al.. (2019). A feedforward relationship between active Rac1 and phosphorylated Bcl-2 is critical for sustaining Bcl-2 phosphorylation and promoting cancer progression. Cancer Letters. 457. 151–167. 22 indexed citations
16.
Chong, Stephen Jun Fei & Shazib Pervaiz. (2018). Bcl-2 phosphorylation permits a conducive pro-oxidant milieu for cancer cell survival and progression. Free Radical Biology and Medicine. 128. S65–S65. 3 indexed citations
17.
Chong, Stephen Jun Fei, et al.. (2017). Reactive Oxygen Species and Oncoprotein Signaling-A Dangerous Liaison. Antioxidants and Redox Signaling. 29(16). 1553–1588. 24 indexed citations
18.
Chong, Stephen Jun Fei, et al.. (2016). The anti-oxidant and pro-oxidant dichotomy of Bcl-2. Biological Chemistry. 397(7). 585–593. 9 indexed citations
19.
Chong, Stephen Jun Fei, Shireen Vali, Ansu Kumar, et al.. (2015). Overexpression of Bcl-2 induces STAT-3 activation via an increase in mitochondrial superoxide. Oncotarget. 6(33). 34191–34205. 34 indexed citations
20.
Chong, Stephen Jun Fei, Ivan Cherh Chiet Low, & Shazib Pervaiz. (2014). Mitochondrial ROS and involvement of Bcl-2 as a mitochondrial ROS regulator. Mitochondrion. 19. 39–48. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chenzhong Xu Breakdown of academic impact, for papers by Iha Park Breakdown of academic impact, for papers by Yan Meng Breakdown of academic impact, for papers by Patricia de la Cruz‐Ojeda Breakdown of academic impact, for papers by Marie‐Julie Nokin Breakdown of academic impact, for papers by John Marentette Breakdown of academic impact, for papers by Junyong Han Breakdown of academic impact, for papers by Giselle Pinto de Faria Lopes Breakdown of academic impact, for papers by Mariya Misheva Breakdown of academic impact, for papers by Lingyun Zheng
Rankless by CCL
2026